Cargando…

Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies

Broad-spectrum antiviral therapies hold promise as a first-line defense against emerging viruses by blunting illness severity and spread until vaccines and virus-specific antivirals are developed. The nucleobase favipiravir, often discussed as a broad-spectrum inhibitor, was not effective in recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soto-Acosta, Ruben, Edwards, Tiffany C., Dreis, Christine D., Krishna, Venkatramana D., Cheeran, Maxim C-J., Qiu, Li, Xie, Jiashu, Bonnac, Laurent F., Geraghty, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705664/ https://www.ncbi.nlm.nih.gov/pubmed/34960780 http://dx.doi.org/10.3390/v13122508

Ejemplares similares

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis
por: Qiu, Li, et al.
Publicado: (2018)

Enhanced Remdesivir Analogues to Target SARS-CoV-2
por: Majima, Ryuichi, et al.
Publicado: (2023)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase
por: Jung, Eunkyung, et al.
Publicado: (2022)

Near-Infrared Dyes: Towards Broad-Spectrum Antivirals
por: Mariewskaya, Kseniya A., et al.
Publicado: (2022)

Modified cyclodextrins as broad-spectrum antivirals
por: Jones, Samuel T., et al.
Publicado: (2020)

Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015)

NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin
por: Lipka, Elke, et al.
Publicado: (2022)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Improving properties of the nucleobase analogs T-705/T-1105 as potential antiviral
por: Jia, Xiao, et al.
Publicado: (2021)

Broad spectrum antiviral nucleosides—Our best hope for the future
por: Seley-Radtke, Katherine L., et al.
Publicado: (2021)

The broad-spectrum antiviral functions of IFIT and IFITM proteins
por: Diamond, Michael S., et al.
Publicado: (2012)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020)

Broad-Spectrum Antivirals Derived from Natural Products
por: Tian, Wen-Jun, et al.
Publicado: (2023)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition
por: Goodier, John L., et al.
Publicado: (2015)

Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)
por: Senaweera, Sameera, et al.
Publicado: (2022)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine
por: De Clercq, Erik, et al.
Publicado: (1990)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23
por: Chianese, Annalisa, et al.
Publicado: (2022)

Isatin derivatives as broad-spectrum antiviral agents: the current landscape
por: Elsaman, Tilal, et al.
Publicado: (2022)

Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents
por: Han, Jinhe, et al.
Publicado: (2022)

Broad-Spectrum Extracellular Antiviral Properties of Cucurbit[n]urils
por: Jones, Luke M., et al.
Publicado: (2022)

Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria
por: Raveh, Avi, et al.
Publicado: (2013)

Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022)

GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals
por: Batista, Mariana Nogueira, et al.
Publicado: (2018)

Epimedium koreanum Nakai Displays Broad Spectrum of Antiviral Activity in Vitro and in Vivo by Inducing Cellular Antiviral State
por: Cho, Won-Kyung, et al.
Publicado: (2015)

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
por: Nabeta, Henry W., et al.
Publicado: (2021)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b5p92vb46i7g3skrcd0kqeli2v